EU says still ‘no evidence’ to support restricting use of AstraZeneca vaccine

BERLIN (AP) — The European Medicines Agency says there is “no evidence” that would support restricting use of AstraZeneca’s coronavirus vaccine in any population despite reports of rare blood clots associated with the shot. The comments Wednesday by the head of the European Union regulator contradict the advice given a day earlier by an expert panel in Germany that prompted the government there to restrict the use of the shot in people under 60.  EMA Executive Director Emer Cooke said her agency continues to study reports of new cases as they come in and will provide a further assessment next week.